PROSTAGLANDIN-E(2) RESTORES CANCELLOUS BONE TO IMMOBILIZED LIMB AND ADDS BONE TO OVERLOADED LIMB IN RIGHT HINDLIMB IMMOBILIZATION RATS

被引:26
|
作者
LI, M [1 ]
JEE, WSS [1 ]
KE, HZ [1 ]
LIANG, XG [1 ]
LIN, BY [1 ]
MA, YF [1 ]
SETTERBERG, RB [1 ]
机构
[1] UNIV UTAH,SCH MED,DIV RADIOBIOL,BLDG 586,SALT LAKE CITY,UT 84112
关键词
D O I
10.1016/8756-3282(93)90153-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to determine whether prostaglandin E2 (PGE2) can restore cancellous bone mass and architecture to osteopenic, continuously immobilized (IM), proximal tibial metaphysis (PTM) in female rats. The right hindlimb of three and one-half-month-old Sprague-Dawley female rats were immobilized by right hindlimb immobilization (RHLI) in which the right hindlimb was underloaded and the contralateral left limb was overloaded during ambulation. After 4 or 12 weeks of RHLI, the rats were treated with 3 or 6 mg PGE2/kg/day and RHLI for 8 or 16 weeks. Bone histomorphometry was performed on microradiographs of PTM. Immobilization (IM) induced a transient cancellous bone loss and decreased trabecular thickness, number and node density, and increased free end density that established a new steady state after 4 weeks of IM. Three or 6 mg PGE2/kg/d for 8 weeks beginning at 4 or 12 weeks of IM completely restored cancellous bone mass (+127% to +188%) and structure to the age-related control levels in spite of continuous IM. Another 8 weeks of treatment maintained bone mass and architecture at these levels. No differences in cancellous bone mass and architecture were found between the overloaded PTM or RHLI rats and the age-related controls. However, 3 and 6 mg/kg/d of PGE2 treatment started at 4 or 12 weeks for 8 weeks significantly increased cancellous bone mass in the overloaded PTM (+45 to +74% of untreated controls), and another 8 weeks of treatment maintained bone mass at these levels. Our findings indicate that daily 3 or 6 mg PGE2/kg/d treatment restores and maintains PTM cancellous bone mass in continuously immobilized (right) tibiae, and adds and maintains extra bone to slightly overloaded PTM cancellous bone in female rats.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 50 条
  • [41] Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2
    A. M. Ozturk
    E. Cila
    U. Kanatli
    I. Isik
    A. Senkoylu
    D. Uzunok
    E. Piskin
    International Orthopaedics, 2005, 29 : 73 - 77
  • [42] PROSTAGLANDIN-E2 ENHANCES CORTICAL BONE MASS AND ACTIVATES INTRACORTICAL BONE REMODELING IN INTACT AND OVARIECTOMIZED FEMALE RATS
    JEE, WSS
    MORI, S
    LI, XJ
    CHAN, S
    BONE, 1990, 11 (04) : 253 - 266
  • [43] A non-prostanoid EP4 receptor selective prostaglandin E2 (PGE2) agonist stimulates bone formation and restores bone mass and strength in ovariectomized rats.
    Ke, HZ
    Crawford, DT
    Ol, H
    Li, M
    Paralkar, VM
    Owen, TA
    Pan, LC
    Brown, TA
    Cameron, KO
    Lefker, BA
    DaSilva-Jardine, P
    Lu, B
    Grasser, WA
    Simmons, HA
    Yu, LJ
    Scott, DO
    Thompson, DD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S483 - S483
  • [44] Prostaglandin E2 causes an anabolic response in bone in pituitary deficient rats.
    Chen, MM
    Yeh, JK
    Aloia, JF
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : T558 - T558
  • [45] Droloxifene does not blunt the bone anabolic effects of prostaglandin E(2) (PGE(2)) but maintains the PGE(2)-restored bone in osteopenic rats.
    Thompson, DD
    Oi, H
    Crawford, DT
    Pirie, CM
    Simmons, HA
    Ke, HZ
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : 1 - 1
  • [46] EFFECTS OF LONG-TERM DAILY ADMINISTRATION OF PROSTAGLANDIN-E2 ON MAINTAINING ELEVATED PROXIMAL TIBIAL METAPHYSEAL CANCELLOUS BONE MASS IN MALE-RATS
    KE, HZ
    JEE, WSS
    MORI, S
    LI, XJ
    KIMMEL, DB
    CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (03) : 245 - 252
  • [47] CONTINUOUS-INFUSION OF PROSTAGLANDIN-E2 STIMULATES BONE-FORMATION AND INCREASES BONE-MINERAL DENSITY IN RATS
    TAKADA, M
    YAMAMOTO, I
    YUU, I
    KIGAMI, Y
    OHNAKA, Y
    MORITA, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S312 - S312
  • [48] PROSTAGLANDIN-E(2) AND PGF(2-ALPHA) PRODUCE BIPHASIC MITOGENIC DOSE RESPONSES IN HUMAN BONE-CELLS IN-VITRO
    BAYLINK, T
    MOHAN, S
    LINKHART, T
    BAYLINK, D
    CLINICAL RESEARCH, 1994, 42 (01): : A49 - A49
  • [49] IN-VITRO CHARACTERIZATION AND IN-VIVO EFFICACY OF A PROSTAGLANDIN-E(2) POLY(ORTHO ESTER) IMPLANT FOR BONE-GROWTH PROMOTION
    APPEL, LE
    BALENA, R
    CORTESE, M
    OPAS, E
    RODAN, G
    SEEDOR, G
    ZENTNER, GM
    JOURNAL OF CONTROLLED RELEASE, 1993, 26 (02) : 77 - 85
  • [50] THE TUMOR-PROMOTING LACTONE, THAPSIGARGIN, INHIBITS BONE-RESORPTION AND STIMULATES PROSTAGLANDIN-E(2) FORMATION IN CULTURED MOUSE CALVARIA
    RANSJO, M
    LERNER, UH
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S248 - S248